ArticleslgStudy

chemistry

GSK2606414

GSK2606414 is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand GSK2606414 rather than just read about it. In short: GSK2606414 is a drug which is the first selective inhibitor discovered for the enzyme protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK), which is involved in various processes relating to cancer and neurodegenerative disorders. GSK2606414 was found to be a potent and selective inhibitor of PERK, with good oral bioavailability and blood-brain barrier penetration.

GSK2606414 — main illustration
GSK2606414 — illustration

Key takeaways

  • GSK2606414 belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect GSK2606414 to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of GSK2606414 from memory before moving on to harder problems.

Reference excerpt

GSK2606414 is a drug which is the first selective inhibitor discovered for the enzyme protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK), which is involved in various processes relating to cancer and neurodegenerative disorders. GSK2606414 was found to be a potent and selective inhibitor of PERK, with good oral bioavailability and blood-brain barrier penetration. PERK mediates the unfolded protein response pathway which is involved in the initiation of protein synthesis, and this pathway has been implicated in the neurotoxicity of various diseases including prion and Alzheimer's diseases. Treatment with GSK2606414 was found to be neuroprotective in mice against damage caused by prions, and prevented the development of cognitive deficits and other clinical manifestations of prion disease. Extension of lifespan in treated mice was, however, not recorded. However, side effects such as weight loss and elevated blood glucose levels were also observed, likely due to unwanted inhibition of PERK in the pancreas gland, where it is involved in regulating insulin production.

References

Illustrations

GSK2606414 illustration

Worked examples

Example 1 — a first encounter with GSK2606414

Start with the simplest possible case. Write down what GSK2606414 claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to GSK2606414 before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about GSK2606414 ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of GSK2606414

In research
GSK2606414 appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses GSK2606414 in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
GSK2606414 is common in secondary-school and first-year university syllabi. It links to neighbouring topics 3-(Trifluoromethyl)phenyl compounds, Drugs acting on the nervous system, Nervous system drug stubs, so understanding it makes those chapters shorter.
In everyday life
Look for GSK2606414 outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “GSK2606414” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study GSK2606414 in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what GSK2606414 means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain GSK2606414 out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is GSK2606414 in simple terms?

GSK2606414 is a drug which is the first selective inhibitor discovered for the enzyme protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK), which is involved in various processes relating to cancer and neurodegenerative disorders. GSK2606414 was found to be a potent and selective inhibit…

Why does GSK2606414 matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study GSK2606414?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on GSK2606414.

Tags

  • 3-(Trifluoromethyl)phenyl compounds
  • Drugs acting on the nervous system
  • Nervous system drug stubs

Keep exploring